Navigation Links
New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
Date:8/23/2013

CHAPEL HILL, N.C., Aug. 23, 2013 /PRNewswire/ -- High-performing pharmaceutical and medical device companies are continually adjusting their Medical Affairs structures to cope with industry and market changes. As the global healthcare landscape continues to expand, Medical Affairs executives must build and maintain strong relationships with physicians and other key members of the medical community across the ever-growing worldwide marketplace.   

A new study by leading research and consulting firm Best Practices, LLC examines critical Medical Affairs capabilities in not only mature markets, but also emerging markets and India in particular. Medical Affairs has grown into a global function, especially in India where 89 percent of the companies that participated in the research study have established dedicated Medical Affairs groups in their organization.

To address the needs of Medical Affairs leaders in mature markets as well as developing markets, the study, "Building Best-in-Class Medical Affairs Capabilities In India- A Case Study For High-Growth Emerging Markets," provides executives with need-to-know comparative metrics, executive insights and best practices from Medical Affairs leaders throughout the healthcare industry.

Key topics addressed in the report will:

  • Illustrate How Leading Global and Indian Pharma & Medical Device Companies Structure & Organize Their Medical Affairs Functions Based On Industry & Market Changes
  • Identify Trends Expected To Impact The Allocation Of Resources Across Different Medical Affairs Functions.
  • Analyze How Regulatory Requirements Are Internalized And Managed By Medical Affairs.
  • Describe The Success Factors And Top Current Challenges Regarding Global & Indian Medical Affairs.
  • Identify What Percentage Of Medical Affairs Budget Leading Companies Allocate To Outsourcing.
  • Trace How Successful Medical Affairs Organizations Work Cross-Functionally To Enhance Effectiveness.

This benchmarking research drew participation from 68 Medical Affairs leaders at 50 top pharmaceutical and medical device companies across mature global markets. In addition, the study presents a segment from India-based organizations.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1230.htm.

For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
2. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
5. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
6. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
8. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
9. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
10. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
11. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... In response to meager ... are unaware of the plight of aphasia. In collaboration with the American Aphasia ... campaign. , The link between stroke and aphasia is relatively unknown, but through ...
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... has a significant negative impact on long-term patient survival, reports a team of ... published online this week in the Journal of Thoracic and Cardiovascular Surgery, provide ...
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey ... , The 550 employees of Sun Health Senior Living (SHSL) may not ... reduces their doctor and prescription copays for the year, while holding the line on ...
Breaking Medicine News(10 mins):